# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1837435 | Binding | Activity of mouse his-tagged ctMGAM-N2 expressed in Sf9 cells assessed as amount of glucose produced after 45 mins by glucose oxidase assay | Mus musculus | 1 | ALA1833806 | cell-based format | Scientific Literature | |
2. | ALA1837436 | Binding | Activity of mouse his-tagged ctMGAM-N20 expressed in Sf9 cells assessed as amount of glucose produced after 45 mins by glucose oxidase assay | Mus musculus | 1 | ALA1833806 | cell-based format | Scientific Literature | |
3. | ALA1837437 | Binding | Activity of mouse his-tagged ctSI expressed in Sf9 cells assessed as amount of glucose produced after 45 mins by glucose oxidase assay | Mus musculus | 1 | ALA1833806 | cell-based format | Scientific Literature | |
4. | ALA1837438 | Binding | Activity of human ntSI expressed in Drosophila S2 cells assessed as amount of glucose produced after 45 mins by glucose oxidase assay | Homo sapiens | 1 | ALA1833806 | cell-based format | Scientific Literature | |
5. | ALA1837439 | Binding | Activity of human ntMGAM expressed in Drosophila S2 cells assessed as amount of glucose produced after 45 mins by glucose oxidase assay | Homo sapiens | 1 | ALA1833806 | cell-based format | Scientific Literature | |
6. | ALA1837440 | Binding | Ratio of Km for mouse ctMGAM-N20 to Km for mouse ctMGAM-N2 | Mus musculus | 1 | ALA1833806 | assay format | Scientific Literature | |
7. | ALA1837441 | Binding | Inhibition of mouse his-tagged ctMGAM-N2 expressed in Sf9 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay | Mus musculus | 7 | ALA1833806 | cell-based format | Scientific Literature | |
8. | ALA1837442 | Binding | Inhibition of mouse his-tagged ctMGAM-N20 expressed in Sf9 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay | Mus musculus | 7 | ALA1833806 | cell-based format | Scientific Literature | |
9. | ALA1837444 | Binding | Inhibition of mouse his-tagged ctSI expressed in Sf9 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay | Mus musculus | 7 | ALA1833806 | cell-based format | Scientific Literature | |
10. | ALA1697855 | ADME | Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset | 484 | ALA1697821 | assay format | Scientific Literature | ||
11. | ALA4303805 | Functional | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging | Homo sapiens | 5,612 | ALA4303101 | organism-based format | SARS-CoV-2 Screening Data 2020-21 | |
12. | ALA4495582 | Functional | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | Severe acute respiratory syndrome coronavirus 2 | 7,212 | ALA4495564 | assay format | SARS-CoV-2 Screening Data 2020-21 | |
13. | ALA4513082 | Functional | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | Chlorocebus sabaeus | 7,212 | ALA4495565 | organism-based format | SARS-CoV-2 Screening Data 2020-21 | |
14. | ALA4651403 | Functional | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | Chlorocebus sabaeus | 4,309 | ALA4651402 | organism-based format | IMI-CARE SARS-CoV-2 Data | |
15. | ALA4808149 | Binding | Enzymatic assay of human HDAC6 with commercial peptide substrate | Homo sapiens | 5,603 | ALA4808148 | single protein format | Fraunhofer HDAC6 | |
16. | ALA4808150 | Binding | Enzymatic assay of human HDAC6 with custom peptide substrate | Homo sapiens | 5,603 | ALA4808148 | single protein format | Fraunhofer HDAC6 |